European Journal of Preventive Cardiology (EJPC) Journal

Overview
Identity
View All

publication venue for

Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease 2023
The cardiometabolic consequences of workplace sexual harassment. 31:1643-1644. 2024
External validation and comparison of six cardiovascular risk prediction models in the Prospective Urban Rural Epidemiology (PURE)-Colombia study. zwae242. 2024
Triglyceride-glucose index, low-density lipoprotein levels, and cardiovascular outcomes in chronic stable cardiovascular disease: results from the ONTARGET and TRANSCEND trials. 31:311-319. 2024
Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort. 30:709-718. 2023
The role of free fatty acids as a prognostic biomarker in coronary artery disease patients with type 2 diabetes. 30:728-729. 2023
Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease. 30:535-545. 2023
Performance of current risk stratification models for predicting mortality in patients with heart failure: a systematic review and meta-analysis. 29:2027-2048. 2022
Medications for blood pressure, blood glucose, lipids, and anti-thrombotic medications: relationship with cardiovascular disease and death in adults from 21 high-, middle-, and low-income countries with an elevated body mass index. 29:1817-1826. 2022
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study. 29:1334-1342. 2022
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. 29:e181-e189. 2022
The Admit-AF risk score: A clinical risk score for predicting hospital admissions in patients with atrial fibrillation. 28:624-630. 2021
Does tooth brushing protect from atrial fibrillation and heart failure?. 27:1832-1834. 2020
Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table. 27:682-692. 2020
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial. 27:296-307. 2020
Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study. 26:681-697. 2019
Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial. 26:847-854. 2019
Healthy lifestyle and prevention of atrial fibrillation: Weighty matters. 25:1371-1373. 2018
Burden of carotid artery atherosclerosis in Chinese adults: Implications for future risk of cardiovascular diseases. 24:647-656. 2017
The left atrium: An overlooked prognostic tool. 24:389-391. 2017
Ethnic differences in case fatality following an acute ischaemic heart disease event in New Zealand: ANZACS-QI 13. 23:1823-1830. 2016
Healthy lifestyle and heart rate variability in young adults. 23:1037-1044. 2016
Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study. 22:1261-1271. 2015
Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians. 22:468-477. 2015
Tobacco use, smoking quit rates, and socioeconomic patterning among men and women: a cross-sectional survey in rural Andhra Pradesh, India. 21:1308-1318. 2014
Effect of referral strategies on access to cardiac rehabilitation among women. 21:1018-1025. 2014
Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. 21:400-410. 2014
Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients. 21:272-280. 2014
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial. 21:299-309. 2014
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16. 21:192-202. 2014
Relation between pulmonary function and 10-year risk for cardiovascular disease among healthy men and women in Italy: the Moli-sani Project. 20:862-871. 2013
Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. 19:755-764. 2012
Effect of combined aerobic and resistance training versus aerobic training alone in individuals with coronary artery disease: a meta-analysis. 19:81-94. 2012
Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. 17:706-712. 2010
Prevalence of cardiovascular risk factors in the Middle East: a systematic review. 16:268-280. 2009
Sex differences in completion of a 12-month cardiac rehabilitation programme: an analysis of 5922 women and men. 15:698-703. 2008
Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?. 15:608-615. 2008
The effects of exercise training on insulin resistance in patients with coronary artery disease. 14:803-808. 2007
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. 14:312-318. 2007
Association between physical activity, adiposity, and lipid abnormalities in children with familial hyperlipidemia. 14:59-64. 2007
Predicting cardiac rehabilitation enrollment: the role of automatic physician referral.. 13:60-66. 2006
Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial. 12:75-81. 2005
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.. 11:460-465. 2004
Differences in sustainability of exercise and health-related quality of life outcomes following home or hospital-based cardiac rehabilitation. 11:313-319. 2004
Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients. 10:420-428. 2003
Tackling the growing global burden of atherosclerotic cardiovascular diseases. 10:236-239. 2003
TBARS and cardiovascular disease in a population-based sample.. 8:219-225. 2001
The role of resistance training in patients with cardiac disease. 3:160-166. 1996
Effects of ACE Inhibitors on Mortality When Started in the Early Phase of Myocardial Infarction: Evidence from the Larger Randomized Controlled Trials. 2:423-428. 1995